McEnany Patrick J's Form 4 filing
Catalyst Pharmaceuticals, Inc. (CPRX) · filed May 17, 2023
- Accession no.
- 0001161697-23-000300
- Filed
- May 17, 2023
- Trade date
- May 15-16, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $346.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| McEnany Patrick JCIK 0000929985 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 15, 2023 | Common stock, par value $0.001 per share | MOption exerciseAcquired | +26,151 | $0.79 | +$20,659.29 | 3,971,587 | Direct | |
| May 15, 2023 | Common stock, par value $0.001 per share | SSaleDisposed | −26,151 | $13.23F2 | −$345,977.73 | 3,945,436 | Direct | |
| May 16, 2023 | Common stock, par value $0.001 per share | MOption exerciseAcquired | +173,849 | $0.79 | +$137,340.71 | 4,119,285 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 15, 2023 | Common Stock | MOption exerciseDisposed | −26,151 | $0.00 | $0 | 3,101,516 | Direct | |
| May 16, 2023 | Common Stock | MOption exerciseDisposed | −173,849 | $0.00 | $0 | 2,927,667 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $13.20 to $13.285 per share.
Referenced by the price of 1 transaction in Table I.